HIV vaccine design and the neutralizing antibody problem, Nature Immunology, vol.74, issue.3, pp.233-236, 2004. ,
DOI : 10.1038/ni0304-233
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates, Expert Review of Vaccines, vol.5, issue.3, pp.347-363, 2006. ,
DOI : 10.1586/14760584.5.3.347
Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proceedings of the National Academy of Sciences, vol.100, issue.7, pp.4144-4149, 2003. ,
DOI : 10.1073/pnas.0630530100
Human Immunodeficiency Virus Type 1 Variants Isolated from Single Plasma Samples Display a Wide Spectrum of Neutralization Sensitivity, Journal of Virology, vol.79, issue.18, pp.11848-11857, 2005. ,
DOI : 10.1128/JVI.79.18.11848-11857.2005
Antibody neutralization and escape by HIV-1, Nature, vol.422, issue.6929, pp.307-312, 2003. ,
DOI : 10.1038/nature01470
HIV???1 Virologic and Immunologic Progression and Initiation of Antiretroviral Therapy among HIV???1???Infected Subjects in a Trial of the Efficacy of Recombinant Glycoprotein 120 Vaccine, The Journal of Infectious Diseases, vol.192, issue.6, pp.974-983, 2005. ,
DOI : 10.1086/432734
Defining the Protective Antibody Response for HIV-1, Current Molecular Medicine, vol.3, issue.3, pp.209-216, 2003. ,
DOI : 10.2174/1566524033479799
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies, Nature Medicine, vol.14, issue.6, pp.615-622, 2005. ,
DOI : 10.1016/j.virol.2004.05.022
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.332, issue.4, pp.201-208, 1995. ,
DOI : 10.1056/NEJM199501263320401
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection, AIDS, vol.12, issue.13, pp.1591-1600, 1988. ,
DOI : 10.1097/00002030-199813000-00005
Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term Nonprogressors, Journal of Infectious Diseases, vol.173, issue.1, pp.60-67, 1996. ,
DOI : 10.1093/infdis/173.1.60
Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long???Term???Nonprogressive Infection, The Journal of Infectious Diseases, vol.176, issue.4, pp.924-932, 1997. ,
DOI : 10.1086/516508
Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV???1) Isolates in Two Groups of HIV???1???Infected Long???Term Nonprogressors, The Journal of Infectious Diseases, vol.176, issue.5, pp.1180-1187, 1997. ,
DOI : 10.1086/514111
Combination of HIV???1???Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long???Term Nonprogression, The Journal of Infectious Diseases, vol.191, issue.12, pp.2053-2063, 2005. ,
DOI : 10.1086/430320
Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007. ,
DOI : 10.1016/j.immuni.2007.08.010
HIV controllers: how do they tame the virus?, Trends in Immunology, vol.28, issue.12, pp.532-540, 2007. ,
DOI : 10.1016/j.it.2007.09.002
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proceedings of the National Academy of Sciences, vol.97, issue.6, pp.2709-2714, 2000. ,
DOI : 10.1073/pnas.050567397
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006. ,
DOI : 10.1182/blood-2005-12-4818
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002. ,
DOI : 10.1038/ni845
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6776-6781, 2007. ,
DOI : 10.1073/pnas.0611244104
URL : https://hal.archives-ouvertes.fr/pasteur-00142658
Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study, Journal of Virology, vol.81, issue.24, pp.13904-13915, 2007. ,
DOI : 10.1128/JVI.01401-07
URL : https://hal.archives-ouvertes.fr/pasteur-00193768
Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection, AIDS Research and Human Retroviruses, vol.12, issue.7, pp.585-592, 1996. ,
DOI : 10.1089/aid.1996.12.585
Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy, Journal of Virology, vol.80, issue.10, pp.4758-4770, 2006. ,
DOI : 10.1128/JVI.80.10.4758-4770.2006
Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.4, pp.563-571, 2008. ,
DOI : 10.1086/526786
Fc receptor but not complement binding is important in antibody protection against HIV, Nature, vol.75, issue.7158, pp.101-104, 2007. ,
DOI : 10.1038/nature06106
Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation, Blood, vol.107, issue.11, pp.4466-4474, 2006. ,
DOI : 10.1182/blood-2005-08-3490
Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac251, The Journal of Immunology, vol.174, issue.4, pp.2185-2189, 2005. ,
DOI : 10.4049/jimmunol.174.4.2185
HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005. ,
DOI : 10.1086/433188
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia, Journal of Virology, vol.82, issue.24, pp.12449-12463, 2008. ,
DOI : 10.1128/JVI.01708-08
Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles, Journal of Virology, vol.81, issue.20, pp.10869-10878, 2007. ,
DOI : 10.1128/JVI.00542-07
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies, Science, vol.308, issue.5730, pp.1906-1908, 2005. ,
DOI : 10.1126/science.1111781
HIV-1 gp41 Envelope Residues 650-685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide, Journal of Biological Chemistry, vol.277, issue.28, pp.25649-25659, 2002. ,
DOI : 10.1074/jbc.M200554200
Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines, Journal of Virology, vol.79, issue.16, pp.10103-10107, 2005. ,
DOI : 10.1128/JVI.79.16.10103-10107.2005
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies, Journal of Virology, vol.79, issue.16, pp.10108-10125, 2005. ,
DOI : 10.1128/JVI.79.16.10108-10125.2005
Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells, Journal of Virology, vol.76, issue.10, pp.4810-4821, 2002. ,
DOI : 10.1128/JVI.76.10.4810-4821.2002
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers, Vaccine, vol.25, issue.3, pp.510-518, 2007. ,
DOI : 10.1016/j.vaccine.2006.07.050
Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)???Specific T Cell Responses in Primary HIV Infection, The Journal of Infectious Diseases, vol.187, issue.5, pp.748-757, 2003. ,
DOI : 10.1086/368333
HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control, Journal of Virology, vol.82, issue.11, pp.5398-5407, 2008. ,
DOI : 10.1128/JVI.02176-07
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C, Journal of Virology, vol.82, issue.23, pp.11651-11668, 2008. ,
DOI : 10.1128/JVI.01762-08
Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.82, issue.11, pp.5548-5561, 2008. ,
DOI : 10.1128/JVI.00124-08